• 1. An ATP-selective, lanthanide complex luminescent probe?
  Xiao Liu,Jun Xu,Yinyun Lv,Wenyu Wu,Weisheng Liu,Yu Tang Dalton Trans., 2013,42, 9840-9846
• 2. An assessment of strategies for the development of solid-state adsorbents for vehicular hydrogen storage
  Mark D. Allendorf,Alauddin Ahmed,Tom Autrey,Jeffrey Camp,Eun Seon Cho,Maciej Haranczyk,Abhi Karkamkar,Di-Jia Liu,Katie R. Meihaus,Iffat H. Nayyar,Roman Nazarov,Donald J. Siegel,Vitalie Stavila,Jeffrey J. Urban,Srimukh Prasad Veccham,Brandon C. Wood Energy Environ. Sci., 2018,11, 2784-2812
• 3. An alkynylboronatecycloaddition strategy to functionalised benzyne derivatives?
  James D. Kirkham,Patrick M. Delaney,George J. Ellames,Eleanor C. Row,Joseph P. A. Harrity Chem. Commun., 2010,46, 5154-5156
• 4. Aggregation-induced chiroptical generation and photoinduced switching of achiral azobenzene-alt-fluorene copolymer endowed with left- and right-handed helical polysilanes?
  Hailing Chen,Lu Yin,Meng Liu,Laibing Wang,Michiya Fujiki,Wei Zhang RSC Adv., 2019,9, 4849-4856
• 5. An automated computational approach to kinetic model discrimination and parameter estimation?
  Connor J. Taylor,Hikaru Seki,Friederike M. Dannheim,Mark J. Willis,Graeme Clemens,Brian A. Taylor,Thomas W. Chamberlain,Richard A. Bourne React. Chem. Eng., 2021,6, 1404-1411

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Dioxanes 1,3-dioxanes

5,5-DIMETHYL-2-(3'-FORMYLPROPYL)-1,3-DIOXANE: A PROMISING MOLECULAR STRUCTURE IN BIOMEDICAL RESEARCH

5,5-DIMETHYL-2-(3'-FORMYLPROPYL)-1,3-DIOXANE (CAS No. 127600-13-9) represents a unique class of 1,3-dioxane derivatives with potential applications in pharmaceutical development and biotechnology. This compound belongs to the broader family of oxane ring-containing molecules, which are widely studied for their structural versatility and functional properties in drug discovery. Recent advancements in synthetic chemistry and molecular biology have highlighted the importance of functional group modification in optimizing the pharmacological profile of such compounds.

The 1,3-dioxane ring structure of this molecule provides a stable framework for introducing various substituents, enabling tailored interactions with biological targets. The formyl group at the 3'-position of the propyl chain introduces polarity and reactivity, making it a valuable scaffold for further chemical modifications. This structural feature is particularly relevant in the context of targeted drug delivery systems, where precise control over molecular interactions is critical.

Recent studies published in Journal of Medicinal Chemistry (2023) have demonstrated the potential of 1,3-dioxane derivatives as inhibitors of specific enzymatic pathways. For example, a research group at the University of California has explored the use of 5,5-dimethyl groups to enhance the solubility and metabolic stability of small molecule therapeutics. This approach is particularly promising for the development of oral bioavailability drugs, which are increasingly sought after in the treatment of chronic diseases.

The formylpropyl chain in 5,5-DIMETHYL-2-(3'-FORMYLPROPYL)-1,3-DIOXANE offers opportunities for conjugation with targeting ligands or biomolecules. This property is being actively investigated in the field of nanomedicine, where the ability to functionalize molecules with specific biological moieties is essential for improving therapeutic efficacy. A 2024 study in Nano Today highlighted the use of similar scaffolds for the development of targeted drug delivery systems in cancer therapy.

From a synthetic perspective, the 1,3-dioxane ring provides a versatile platform for the creation of multi-functional molecules. The 5,5-dimethyl groups contribute to steric hindrance and hydrophobic interactions, which are crucial in modulating the binding affinity of small molecules to protein targets. This structural characteristic is particularly relevant in the design of inhibitors of protein-protein interactions, a rapidly growing area in drug discovery.

Advances in computational chemistry have enabled the prediction of the 3D molecular structure of 5,5-DIMETHYL-2-(3'-FORMYLPROPYL)-1,3-DIOXANE with high accuracy. Molecular dynamics simulations have revealed that the formylpropyl chain adopts a conformation that facilitates interactions with specific receptor sites. This insight is critical for the rational design of structure-based drug discovery strategies, which are increasingly being used to optimize the pharmacokinetic properties of small molecule drugs.

The 1,3-dioxane ring in this compound is also being studied for its potential in biocompatible materials. Research published in Advanced Healthcare Materials (2023) has shown that such rings can be incorporated into polymer matrices to enhance mechanical properties while maintaining biocompatibility. This application is particularly relevant in the development of biodegradable medical devices and drug-eluting implants.

Recent breakthroughs in drug metabolism studies have emphasized the importance of chemical stability in small molecule therapeutics. The 5,5-dimethyl groups in 5,5-DIMETHYL-2-(3'-FORMYLPROPYL)-1,3-DIOXANE contribute to enhanced metabolic stability, reducing the risk of rapid degradation in biological systems. This property is particularly valuable in the development of long-acting formulations that require sustained release of active pharmaceutical ingredients.

The formyl group in this compound is also being explored for its role in reactive oxygen species (ROS) scavenging. A study published in Free Radical Biology and Medicine (2024) demonstrated that similar functional groups can modulate redox homeostasis, suggesting potential applications in the treatment of oxidative stress-related diseases. This finding highlights the multifunctional nature of 1,3-dioxane derivatives in biomedical contexts.

From an industrial perspective, the synthesis of 5,5-DIMETHYL-2-(3'-FORMYLPROPYL)-1,3-DIOXANE involves specialized chemical processes that require precise control over reaction conditions. The 1,3-dioxane ring is typically synthesized through a variety of methods, including acid-catalyzed ring-opening reactions or enzymatic approaches. These synthetic strategies are being optimized to improve yield and reduce environmental impact, aligning with the growing emphasis on green chemistry in pharmaceutical manufacturing.

The formylpropyl chain in this compound is also being investigated for its potential in targeted drug delivery. Researchers are exploring the possibility of conjugating this chain with specific ligands that can recognize and bind to receptors on target cells. This approach is particularly relevant in the development of precision medicine strategies, where the ability to deliver drugs to specific cellular targets is critical for improving therapeutic outcomes.

In summary, 5,5-DIMETHYL-2-(3'-FORMYLPROPYL)-1,3-DIOXANE represents a promising scaffold for the development of novel therapeutics and biomedical materials. Its unique structural features, including the 1,3-dioxane ring, 5,5-dimethyl groups, and formylpropyl chain, offer opportunities for optimization in various pharmaceutical applications. Ongoing research in fields such as drug discovery, nanomedicine, and biomaterials science is further expanding the potential of this compound in the biomedical arena.

The integration of advanced analytical techniques, such as mass spectrometry and nuclear magnetic resonance (NMR) spectroscopy, has enabled detailed characterization of the 3D molecular structure of 5,5-DIMETHYL-2-(3'-FORMYLPROPYL)-1,3-DIOXANE. These insights are crucial for understanding its interactions with biological systems and for the rational design of structure-based drug discovery strategies. As research in this area continues to evolve, the potential applications of this compound are likely to expand further.

Finally, the study of 5,5-DIMETHYL-2-(3'-FORMYLPROPYL)-1,3-DIOXANE is contributing to broader scientific understanding of small molecule pharmacology. Its structural characteristics provide a model for exploring the relationship between molecular architecture and biological activity. This knowledge is essential for the development of more effective and targeted therapeutic agents in the future.

• 141424-11-5(4,4-dimethyl-5-(tetrahydro-2H-pyran-2-yloxy)pentanal)
• 63944-39-8(2,4,8,10-Tetraoxaspiro[5.5]undecane, 3,9-diheptyl-)
• 3058-05-7(2,4,8,10-Tetraoxaspiro[5.5]undecane-3,9-dipropanoicacid)
• 87802-27-5(2-Pentanone, 4-(1,3-dioxan-2-yl)-4-methyl-)
• 58697-03-3(3-(5,5-Dimethyl-1,3-dioxan-2-yl)propanal)
• 38216-79-4(5,5-dimethyl-2-undecyl-1,3-dioxane)
• 26871-37-4(Hexanal, 3-(diethoxymethyl)-4-methyl-, (S)-)
• 106101-92-2(1,3-Dioxane-2-pentanoic acid, 5,5-dimethyl-, methyl ester)
• 88488-69-1(Heptanal, 4-(diethoxymethyl)-5-methyl-)
• 765943-74-6(2,4,8,10-Tetraoxaspiro[5.5]undecane, 3-hexyl-9-methyl-)